Why this series? Technology is shaping the world around us. Every day we come across the new ideas and new technology. We believe in "WE SHARE, WE GROW". We believe in sharing what we learn and learning further by receiving your feedback on IKS@intellectperitus.com
IKS Article No: IKS_Article_07 February_05_2018
Microbial fuel cells (MFCs) seems to be progressing at an amazing speed in the past few years, with higher power density but lower cost being continuously achieved and have created a promising future for us. Thus bioelectricity production technology using microbes can act very well as a sustainable renewable source of energy. Till now, a large number of microbes and a variety of substrates (including waste) have been used to produce electricity. In our study we have identified the documents showing bioelectricity production using bacteria (more preferably Geobacter spp.), where the power output of more than 25W (upto 300 W) is produced using microbial fuel cells......... Read More
IKS Article No: IKS_Article_06 January_22_2018
Deep Learning is recited among top three technologies of year 2017, which is expected to welcome high demand in next few years. It is predicted that the deep learning market is expected to be worth USD 1772.9 Million by 2022, growing at a CAGR of 65.3% between 2016 and 2022. This article mainly focuses on what is Deep Learning, overview of patentability hurdles for Deep Learning in Europe and USA region and few solutions to overcome the hurdles faced........ Read More
IKS Article No: IKS_Article_05 July_20_2017
By 2020, it is predicted that the Biosimilar market globally will cross US$20 Billion. With an increasing number of patent expires and more clear regulation processes, Biosimilars have emerged as one of the fastest-growing categories in the biopharmaceutical sector. The increasing need for cost-effective treatment is one of the major factors driving this market's growth in the coming years. Biosimilars cost 10% to 30% lesser than their parent products which is one of the primary factors fueling their adoption. This article mainly focuses on what is Biosimilar, overview of regulation; products approved related to Biosimilar in USA, Europe & India and few challenges in patent researching and analysis related to Biosimilars..... Read More
IKS Article No: IKS_Article_04 March_01_2017
Mergers, acquisitions and alliances are in the spotlight as companies seek innovation to redefine their strategy. Over the past 2 years, diversified industrial companies experienced persistent pressure to reduce costs and restructure in the face of sluggish market conditions and a low growth environment. To stay competitive, companies strategically acquired new technology that improved processes and efficiencies. .... Read More
IKS Article No: IKS_Article_03 September_25_2015
In world fastest growing IP industry, to make effective patent searching, every patent searcher must know the crucial language based challenges and due to complex, rich and inconsistent nature with a huge vocabulary and numerous synonyms make English language more problematic. .... Read More
IKS Article No: IKS_Article_02 May_25_2015
Citations represent added value from the patent office which we can use to help formulate better patent searches. Importantly, citations provide a language-independent search tool. This is of increasing importance in our global economy where applications are published around the world in many different languages. Links between cited references are now available in many databases free and fee-based and those links between patents related by subject can be exploited in a search to improve both relevance and recall. Cited references can provide access to older documents, which cannot be keyword searched or where terminology has changed. .... Read More
IKS Article No: IKS_Article_01 May_15_2015
In recent time, to make effective search strategies for searching patent literature, every searcher must know about few basic challenges of patent searching. .... Read More